Join the Horizant group to help and get support from people like you.
Horizant News
Gabapentin Doesn't Increase Fall Risk, Study Suggests
THURSDAY, Jan. 9, 2025 – A pain-relieving medication might be safer for seniors than first thought. A new study published Jan. 7 in the Annals of Internal Medicine says Gabapentin is widely used to...
Incident Gabapentin Use Not Linked to Increase in Falls Versus Duloxetine
TUESDAY, Jan. 7, 2025 – Incident use of gabapentin is not associated with an increase in fall-related hospital visits compared with duloxetine use, according to a study published online Jan. 7 in...
Guidelines Developed for Treatment of Restless Legs Syndrome
MONDAY, Dec. 2, 2024 – In a clinical practice guideline issued by the American Academy of Sleep Medicine and published online Sept. 26 in the Journal of Clinical Sleep Medicine, recommendations are ...
Gabapentinoid Use Tied to Higher Risk for Hip Fractures
MONDAY, Nov. 18, 2024 – Gabapentinoid use is associated with an increased risk for hip fractures, according to a study published online Nov. 13 in JAMA Network Open. Miriam T.Y. Leung, from the ...
FDA Medwatch Alert: FDA Warns About Serious Breathing Problems with Seizure and Nerve Pain Medicines Gabapentin (Neurontin, Gralise, Horizant) and Pregabalin (Lyrica, Lyrica CR) in Patients with Respiratory Risk Factors
December 19, 2019 – The U.S. Food and Drug Administration (FDA) is warning that serious breathing difficulties may occur in patients using gabapentin (Neurontin, Gralise, Horizant) or pregabalin...
GSK and XenoPort Receive FDA Approval for Horizant for Postherpetic Neuralgia
LONDON & RESEARCH TRIANGLE PARK, N.C. & SANTA CLARA, Calif.--(BUSINESS WIRE)--Jun 7, 2012 - GlaxoSmithKline plc and XenoPort, Inc. announced today that the United States (US) Food and Drug...
Further information
Related condition support groups
Restless Legs Syndrome, Persisting Pain, Shingles, Postherpetic Neuralgia